INSM

Insmed
INSM

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$12.87B
EV
$12.75B
Shares Outstanding
205.92M
Beta
1.07

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$97.18
P/E 2025E
-
P/Revenue 2025E
27.52x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Insmed Incorporated

gainify
INSM

Insmed Incorporated

INSM

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex l...

Sector

Healthcare

Industry

Biotechnology

CEO

Lewis, William

Employees

1,271

IPO Date

2000-06-01

Headquarters

700 US Highway 202/206, Bridgewater, New Jersey, 08807, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved